NCT05287698

Brief Summary

Suspension laryngoscopy (SL) is a surgical procedure that is widely applied in the diagnosis and treatment of many benign or malignant diseases of the vocal cords and allows bimanual surgery of the endolarynx (Larner et al., 2019). In suspension laryngoscopy, a significant force is exerted on the tongue and neck tissues due to the abutment mechanism used to visualize the larynx and pharynx, which are located deeper than the oral cavity. This force causes symptoms such as sore throat, dysphagia, paresis, cough, taste disorder, oral injury, and hoarseness in the postoperative period (Larner et al., 2019; Tsang et al., 2020; Taliercio et al., 2017).In the literature, it has been reported that patients experience sore throat, cough, dysphagia, and hoarseness symptoms after suspension laryngoscopy (Larner et al., 2019; Taliercio et al., 2017; Okui et al., 2020). Pharmacological and non-pharmacological methods can be applied to prevent sore throat and dysphagia after suspension laryngoscopy. The interventions that start while the patient is still in the recovery room to prevent postoperative sore throat and swallowing difficulties are the responsibility of the recovery unit nurses. Being aware of the problems such as sore throat and swallowing difficulties experienced by patients after suspension laryngoscopy, effective nursing practices should be developed to prevent these problems and their possible consequences. Therefore, the aim of this study is to examine the effect of cold vapor on sore throat and dysphagia in the early postoperative period after suspension laryngoscopy.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 18, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

March 21, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

March 18, 2022

Status Verified

March 1, 2022

Enrollment Period

6 months

First QC Date

March 2, 2022

Last Update Submit

March 10, 2022

Conditions

Keywords

Sore throatDysphagiaLaryngoscopyNursing Care

Outcome Measures

Primary Outcomes (2)

  • Cold vapor

    The Visual Analogue Scale (VAS) of the patients for sore throat who underwent cold vapor is decreased compared to those who do not. A score between 0 and 10 is taken from the VAS. It is good that the score from the VAS has decreased.

    First 24 hours after surgery

  • Cold vapor

    The Numeric Rating Scale (RTS) of the patients for dysphagia who underwent cold vapor is decreased compared to those who do not. A score between 0 and 10 is taken from the RTS. It is good that the score from the RTS has decreased.

    First 24 hours after surgery

Study Arms (2)

Cold vapor group

EXPERIMENTAL

Cold vapor will be applied to the experimental group patients for 15 minutes in the recovery room. For the study, Nebtime UN600A Ultrasonic Nebulizer Device will be used to apply cold steam to the patients which used in the hospital and calibrated (https://elmaslarmedikal.com.tr/urunler/nebtime-un600a-ultrasonik-nebulizator/). The parameters to be set on the device for the cold vapor to be applied to the patients in the early postoperative period will be vapor intensity level 5 (1-10), air blowing intensity 5 (1-10), heater intensity 1 (+10C), and timer 15 minutes. The patients will be evaluated by the researchers in terms of sore throat and dysphagia before and 15 minutes after the cold vapor application in the recovery room and at the 6th, 12th, and 24th hours after the cold vapor application in the postoperative service.

Other: Cold vapor

Control group

NO INTERVENTION

Patients in the control group will receive standard care that includes all medical and non-medical treatments in the hospital. Nursing care, which is routinely applied to patients in the postoperative period, both in the recovery room and in the service, will be continued within the standard care. The patients will be evaluated by the researchers in terms of sore throat and dysphagia when they come to the recovery room and at the 6th,12th, and 24th hours after the surgery in the postoperative service.

Interventions

Before surgery, socio-demographic data of the patients, ASA and Mallampati scores, sore throat level, and dysphagia level will be recorded. After surgery, patients will be evaluated in the recovery room for their suitability to participate in the study with the Ramsay sedation scale and the Modified Aldrete Scale. Cold vapor will be applied to the patients for 15 minutes in the recovery room during the postoperative period. The parameters to be set on the device for the cold vapor to be applied to the patients in the early postoperative period will be vapor intensity level 5, air blowing intensity 5, heater intensity 1 (+10C), and timer 15 minutes. The patients will be evaluated by the researchers in terms of sore throat and dysphagia before and 15 minutes after the cold vapor application in the recovery room and at the 6th, 12th, and 24th hours after the cold vapor application in the postoperative service.

Cold vapor group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being 18 years or older
  • To undergo suspension laryngoscopy
  • Having an ASA score of 1-2 points
  • Not having any respiratory problems before the operation
  • Not having a neurological disease related to swallowing
  • Not having a sore throat due to cancer and chronic diseases
  • Having a Modified Mallampati score of 1-2 points
  • Getting 2 points from the Ramsay Sedation scale in the postoperative recovery room
  • Having a Modified Aldrete score of at least 9 points in the postoperative recovery room
  • The duration of the operation is at least 30 minutes
  • To be willing to participate in the study.

You may not qualify if:

  • To undergo emergency surgery
  • Being under the age of 18
  • Having an ASA score of 3 and above
  • Having any respiratory problems in the preoperative period
  • Having a neurological disease related to swallowing
  • Having a sore throat due to cancer and chronic diseases
  • Having a Modified Mallampati score of 3 or higher
  • The duration of the operation is less than 30 minutes
  • Not agreeing to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (9)

  • Larner SP, Fornelli RA, Griffith SD. Consistent Technique Limits Suspension Laryngoscopy Complications. Int Arch Otorhinolaryngol. 2019 Jul;23(3):e305-e310. doi: 10.1055/s-0039-1684036. Epub 2019 May 28.

    PMID: 31360250BACKGROUND
  • Tsang TM, Brett O, Hu A. Patient Perception and Duration of Pain after Microdirect Laryngoscopy. Otolaryngol Head Neck Surg. 2020 May;162(5):702-708. doi: 10.1177/0194599820907904. Epub 2020 Mar 10.

    PMID: 32151190BACKGROUND
  • Taliercio S, Sanders B, Achlatis S, Fang Y, Branski R, Amin M. Factors Associated With the Use of Postoperative Analgesics in Patients Undergoing Direct Microlaryngoscopy. Ann Otol Rhinol Laryngol. 2017 May;126(5):375-381. doi: 10.1177/0003489417693862. Epub 2017 Feb 1.

    PMID: 28397564BACKGROUND
  • Okui A, Konomi U, Watanabe Y. Complaints and Complications of Microlaryngoscopic Surgery. J Voice. 2020 Nov;34(6):949-955. doi: 10.1016/j.jvoice.2019.05.006. Epub 2019 May 31.

    PMID: 31160183BACKGROUND
  • Jung H, Kim HJ. Dexamethasone contributes to the patient management after ambulatory laryngeal microsurgery by reducing sore throat. Eur Arch Otorhinolaryngol. 2013 Nov;270(12):3115-9. doi: 10.1007/s00405-013-2708-5. Epub 2013 Sep 22.

    PMID: 24057101BACKGROUND
  • Paltura C, Guvenc A, Develioglu ON, Yelken K, Kulekci M. Original Research: Aerosolized Lidocaine: Effective for Safer Arousal After Suspension Laryngoscopy. J Voice. 2020 Jan;34(1):130-133. doi: 10.1016/j.jvoice.2018.08.012. Epub 2018 Sep 15.

    PMID: 30227980BACKGROUND
  • Bulut H, Erden S, Demir SG, Cakar B, Erdogan Z, Demir N, Ay A, Aydin E. The Effect of Cold Vapor Applied for Sore Throat in the Early Postoperative Period. J Perianesth Nurs. 2016 Aug;31(4):291-7. doi: 10.1016/j.jopan.2014.10.005. Epub 2016 Feb 24.

    PMID: 27444760BACKGROUND
  • Sahbaz M, Khorshid L. The Effect of Cold Vapor and Ice Cube Absorption in the Early Postoperative Period on Sore Throat and Hoarseness Induced by Intubation. J Perianesth Nurs. 2020 Oct;35(5):518-524. doi: 10.1016/j.jopan.2019.12.007. Epub 2020 May 10.

    PMID: 32402773BACKGROUND
  • Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016 Feb;17(2):131-57. doi: 10.1016/j.jpain.2015.12.008.

    PMID: 26827847BACKGROUND

Related Links

MeSH Terms

Conditions

PharyngitisDeglutition Disorders

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsPharyngeal DiseasesStomatognathic DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Central Study Contacts

Özlem İbrahimoğlu, PhD

CONTACT

Bülent Evren Erkul, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Patients who were hospitalized for suspension laryngoscopy and met the sample selection criteria will be included in the experimental and control groups by block randomization method using the random numbers table on the computer.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assisstant Professor

Study Record Dates

First Submitted

March 2, 2022

First Posted

March 18, 2022

Study Start

March 21, 2022

Primary Completion

October 1, 2022

Study Completion

December 1, 2022

Last Updated

March 18, 2022

Record last verified: 2022-03